Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Successor to Vioxx fails to quell concerns

When drug company Merck revealed the the results of a study this week over it's successor to Vioxx, the new arthritis drug Arcoxia, it did little to quell concerns about both the use and the safety of the new drug.

15 Nov 2006

Arthritis drugs not as risky as first thought

Researchers now say that two biotech drugs used to treat rheumatoid arthritis, Humira (Abbott Laboratories) and Remicade (Johnson & Johnson), may not raise the risk of cancer and infections as much as was initially feared.

8 Nov 2006

Acupuncture and Turmeric could be viable treatment options for arthritis sufferers

People who suffer from osteoarthritis (OA) as a rule find it has to varying degrees an impact on their mobility and quality of life.

31 Oct 2006

Turmeric for prevention of rheumatoid arthritis and osteoporosis

An ancient spice, long used in traditional Asian medicine, may hold promise for the prevention of both rheumatoid arthritis and osteoporosis, according to a recently completed study at The University of Arizona College of Medicine.

30 Oct 2006

Researchers create roadmap to integrin activation

Calling it an important technical advance in the study of the complex receptors and pathways of the body's cellular system, researchers at the University of California, San Diego (UCSD) School of Medicine have reconstructed the signaling pathways that impact activation of a receptor that is critical to the control of bleeding and to the thrombosis that occurs in heart attacks and strokes.

18 Sep 2006

Are we getting enough vitamin D?

Scientists from the University of Ulster are to explore if we are getting enough vitamin D - vital for the formation of healthy bones and which may also help prevent diseases such as diabetes, cancers, rheumatoid arthritis and multiple sclerosis.

13 Sep 2006

Drug infliximab may help ease ulcerative colitis

In good news for patients with stubborn cases of ulcerative colitis, a serious intestinal disorder, a new research review suggests that the drug infliximab can be a useful alternative if other treatments don't work.

12 Sep 2006

Rheumatoid arthritis drugs appear to work better when delivered into the central nervous system

Rheumatoid arthritis drugs work better, at least in arthritic rats, when delivered into the central nervous system, Gary Firestein and colleagues (University of California San Diego) now report in the international open-access medical journal PLoS Medicine.

4 Sep 2006

New hope for patients with lung and joint disease

People who suffer from inflammatory conditions such as chronic diseases of the lung, joints and other organs could benefit from a new discovery by scientists at the University of Edinburgh.

4 Sep 2006

Bipolar disorder costs twice as much in lost productivity as major depressive disorder

Bipolar disorder costs twice as much in lost productivity as major depressive disorder, a study funded by the National Institutes of Health's (NIH) National Institute of Mental Health (NIMH) has found. Each U.S. worker with bipolar disorder averaged 65.5 lost workdays in a year, compared to 27.2 for major depression.

4 Sep 2006

New cell-based targets for treating autoimmune inflammatory diseases

Patients with systemic autoimmune diseases such as lupus and rheumatoid arthritis (RA) often suffer loss of kidney function.

31 Aug 2006

Tumor necrosis factor A antagonist use and cancer in patients with rheumatoid arthritis

Patients with rheumatoid arthritis (RA), an autoimmune, inflammatory disease marked by progressive joint and organ damage, face a high risk of developing cancer.

31 Aug 2006

Drug trial fiasco induced immune system overload in patients

The doctors who treated six British men in a trial of a drug in March which went horribly wrong, say they believe the men suffered an immune system overreaction known as a cytokine storm.

15 Aug 2006

New treatment for septic shock

A potential new treatment for septic shock and other inflammatory diseases has been discovered by Monash Institute researchers.

14 Aug 2006

Allergies may put you more at risk of Parkinson's disease

According to researchers people who suffer from allergic rhinitis may be more at risk for Parkinson's disease later in life.

9 Aug 2006

Allergic rhinitis linked to the development of Parkinson's disease

Researchers from Mayo Clinic have discovered that allergic rhinitis is associated with the development of Parkinson's disease later in life. Findings will be published in the Aug. 8 issue of the journal Neurology.

7 Aug 2006

Experimental drug trial victim has cancer

One of the men who suffered severe reactions to an experimental drug during a drug trial in London, UK, says he now has cancer.

6 Aug 2006

Smoking interacts with genetic risk factors in the development of rheumatoid arthritis among older Caucasian women

Smoking increases the chance of developing rheumatoid arthritis in women who otherwise lack genetic risk factors for the disease.

2 Aug 2006

Future looks bleak for victims of 'elephant man' drug trial

The men who suffered horrendous reactions during a drug trial in the UK could well be facing developing cancer and other fatal diseases as a result of being poisoned in the test, and are at risk of an early death.

31 Jul 2006

COX-2 inhibitors prescribed to reduce gastrointestinal toxicity prior to the market withdrawals

Nonsteroidal anti-inflammatory drugs (NSAIDs) have been the most popular treatment for arthritis - despite their association with gastrointestinal (GI) complications, including bleeding ulcers and death.

27 Jul 2006

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Successor to Vioxx fails to quell concerns

Arthritis drugs not as risky as first thought

Acupuncture and Turmeric could be viable treatment options for arthritis sufferers

Turmeric for prevention of rheumatoid arthritis and osteoporosis

Researchers create roadmap to integrin activation

Are we getting enough vitamin D?

Drug infliximab may help ease ulcerative colitis

Rheumatoid arthritis drugs appear to work better when delivered into the central nervous system

New hope for patients with lung and joint disease

Bipolar disorder costs twice as much in lost productivity as major depressive disorder

New cell-based targets for treating autoimmune inflammatory diseases

Tumor necrosis factor A antagonist use and cancer in patients with rheumatoid arthritis

Drug trial fiasco induced immune system overload in patients

New treatment for septic shock

Allergies may put you more at risk of Parkinson's disease

Allergic rhinitis linked to the development of Parkinson's disease

Experimental drug trial victim has cancer

Smoking interacts with genetic risk factors in the development of rheumatoid arthritis among older Caucasian women

Future looks bleak for victims of 'elephant man' drug trial

COX-2 inhibitors prescribed to reduce gastrointestinal toxicity prior to the market withdrawals

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in